Compare iShares Global Clean Energy ETF (ICLN) vs Repligen Corporation Common Stock (RGEN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
iShares Global Clean Energy ETF vs Repligen Corporation Common Stock — how do they compare? iShares Global Clean Energy ETF trades at $16.42 (market cap $2.21B), while Repligen Corporation Common Stock trades at $178.15 (market cap $11.14B). The key difference: Repligen Corporation Common Stock is far larger — about 5× iShares Global Clean Energy ETF's market cap, and Repligen Corporation Common Stock is trading nearer its 52-week high, iShares Global Clean Energy ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold iShares Global Clean Energy ETF for 88 Days and Repligen Corporation Common Stock for 0 Days on average.
| ICLN | RGEN | |
|---|---|---|
Market Cap | $2.21B | $11.14B |
Volume | 6,641,356 | 1,259,263 |
52-Week High | $23.75 | $194.57 |
52-Week Low | $16.00 | $102.87 |
Typical Hold Time | 88 Days | 0 Days |
Sector | — | Health |
Enterprise Value | — | $11.02B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ICLN is trading at $16.64, down 2.8% today amid bearish technical signals with 15 sell indicators versus 1 buy. The ETF faces headwinds from clean energy sector volatility, having experienced a 57.2% maximum drawdown historically. Recent news highlights competition from traditional energy ETFs delivering stronger returns with lower fees, though geopolitical tensions are accelerating global renewable energy adoption.
The outlook remains cautious due to high volatility and expense ratio disadvantages versus fossil fuel alternatives. Key risks include sector competition and regulatory uncertainty, while potential catalysts include increased global renewable investment and data center energy demand growth.
RGEN trades at $175.42, up 1.66% today, with a neutral technical signal and key support at $173. The stock has consistently beaten earnings estimates in recent quarters, with Q3 2026 results due October 27. Revenue grew to $738.26M in 2025, though net income margin is modest at 5.29%. The company recently completed the acquisition of BioLife Solutions, signaling strategic expansion.
Outlook remains positive with strong analyst support (91.67% buy ratings) and a consensus price target of $173.86, though high valuation multiples (P/E 240.34) pose a risk. Earnings growth and integration of acquisitions are key catalysts, but investors face execution risks and market volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About iShares Global Clean Energy ETF
The index is designed to track the performance of approximately 100 clean energy-related companies. The fund generally invests at least 80% of its assets in the component securities of the target index. The index may invest up to 20% of its assets in certain futures, trading options and swap contracts, cash and cash equivalents, as well as in securities not included in the index. It is non-diversified.
Read more on ICLN →About Repligen Corporation Common Stock
Repligen Corporation develops and manufactures bioprocessing tools and technologies used in biologic drug manufacturing, including filtration and perfusion systems, chromatography columns and resins, and process analytics instruments. Its products support upstream and downstream production workflows for modalities such as monoclonal antibodies, mRNA, and viral vectors.
Read more on RGEN →
